The latest report on “3D Bioprinting Market (Technology – Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, and Magnetic 3D Bioprinting; Material – Living Cells, Hydrogels, Extracellular Matrices, and Other Materials; Application – Research Applications, Clinical Applications, and Other Applications; End User – Pharmaceutical & Biotechnology Companies, Research Organizations, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025.” The global 3D bioprinting market is projected to grow at a CAGR of 21.40% over the forecast period of 2019-2025.
Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/13155
Technological advancements in the field of manufacturing have evolved the medical and pharmaceutical industries. One of the novel manufacturing techniques is 3D printing and 3D bioprinting is the application of 3D bioprinting in the field of medical and pharmaceuticals. The 3D bioprinting market is relatively new and it is highly fragmented in nature with a number of market players competing to hold a leading position in the market.
The key players in the market including Organovo Holdings Inc., Cellink AB, Cyfuse Biomedical K.K., 3 Dynamics Systems Ltd., Aspect Biosystems Ltd., and others are focusing on strategic collaborations, acquisitions, agreements, and novel product launch to compete in the market. Recently, Organovo Holding, Inc. announced a partnership with L’Oreal for the development of skin tissue with its NovoGen Bioprinting Platform. On the other hand aspect, Biosystems made a collaboration with the Institute for Technology-Inspired Regenerative Medicine (MERLN) at Maastricht University in the Netherlands to develop kidney tissue by the head of bioprinting research.
The rise in the prevalence of chronic diseases such as cancers and degenerative diseases is the major factor driving the global 3D bioprinting market. By using 3D bioprinting techniques, tissues are regenerated to treat cancers and other diseases. Furthermore, an increase in R&D investment in the field of biotechnology is contributing to the growth of the global 3D bioprinting market. Additionally, government initiatives for improving healthcare are also contributing to the growth of the 3D bioprinting market. However, the dearth of skilled professionals is hampering the growth of the global 3D bioprinting market. Nonetheless, the trend of personalized medicine is anticipated to provide favorable opportunities for companies in the 3D bioprinting market.
North America Region Dominated the Global 3D Bioprinting Market, Accounting for the Largest Share in the Market
Region-wise, North America region dominated the global 3D bioprinting market, accounting for the largest share in the market. The large share of the region attributed to the increase in the geriatric population, the presence of major market players, sophisticated healthcare infrastructure and high investment in R&D to develop 3D printing technology. On the other hand, the 3D bioprinting market in the Asia-Pacific region is anticipated to register the highest rate of growth. The fastest growth of the market in this region attributes to a large population base suffering from chronic diseases, and the increasing number of government initiatives to improve healthcare.
The report on the global 3D bioprinting market covers segments such as technology, material, application, and end-user. On the basis of technology, the sub-markets include microextrusion bioprinting, inkjet 3D bioprinting, laser-assisted bioprinting, and magnetic 3D bioprinting. On the basis of material, the sub-markets include living cells, hydrogels, extracellular matrices, and other materials. On the basis of application, the sub-markets include research applications, clinical applications, and other applications. On the basis of end-user, the sub-markets include pharmaceutical & biotechnology companies, research organizations, and other end users.
Browse Detailed TOC and Description of this Exclusive Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-3d-bioprinting-market
The report provides profiles of the companies in the market such as Organovo Holdings Inc., Cellink AB, Luxexcel Group B.V., Cyfuse Biomedical K.K., Nano3D Biosciences, Inc., 3 Dynamics Systems Ltd., Aspect Biosystems Ltd., EnvisionTEC GmbH, Allevi, FUJIFILM Wako Automation Corporation, and other companies.
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of the 3D bioprinting.
=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.
=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.